Risk adapted chemotherapy for localised Ewings sarcoma of bone: The French EW93 study

European Journal of Cancer, 04/27/2012

The results showing a potential benefit of a consolidation strategy including busulfan/melphalan as compared to conventional chemotherapy needed confirmation by a randomised trial and were one of the bases of the ongoing EuroEwing99.

Print Article Summary Cat 2 CME Report